Pathology Biorepository
City of Hope's Pathology Repository, also known as the solid tumor biorepository, serves as a mechanism for the procurement processing, management storage and distribution of fresh and banked human biological materials from patients seen at City of Hope Medical Center ("City of Hope'') and affiliated institutions. These patients have been diagnosed or are suspected of having solid tumor malignancies. Investigators who wish to obtain tissue for research must submit a request form with specifications of the needs of the study in accordance with their study application in iRIS. All proposals for research using freshly procured and banked human biological materials will be reviewed and approved by the appropriate Disease Team, the IRB and BDRC.
Meet the Team
Core Staff
Karen Miller, CLS, MT (ASCP)
Senior Manager
[email protected]
Alysha Baker
Histotechnologist II
[email protected]
Amberlynn Bird
Histotechnologist
[email protected]
Olga Danilova, M.D.
Faculty Lead
[email protected]
Contact the Team
Using the Facility
With consent in place, biospecimens are ethically procured under the supervision of pathologists, processed, stored, and fully annotated following ISBER's Best Practices and National Cancer Institute's Best Practices for Biospecimen Resources, and distributed following all regulatory requirements for research purposes. If you receive care at City of Hope, please understand that we may approach you for permission to use your specimens and medical information about your condition for research. Of course, you are always free to decline.
Current pricing can be found on iLab Solutions.
In a given year, City of Hope conducts more than 400 clinical trials enrolling more than 6,000 patients.
City of Hope is focused on basic and clinical research in cancer, diabetes and other life-threatening diseases.
